訊聯基因 (4160)
訊聯基因 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$48.16M, up 6.5% from a year earlier. EPS over the last four quarters totals NT$0.67.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2012-09-17
- Founded
- 2008-11-21
- Paid-in capital
- NT$280.14M
- Common shares issued
- 28,013,734
- Legal name
- 訊聯基因數位股份有限公司
- Website
- https://www.GGA.Asia
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$48.16M | -7.2% | +6.5% |
| 2026-08 | NT$51.90M | -11.8% | +11.5% |
Year to date: +5.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.23 |
| 2026 Q1 | 0.01 |
| 2025 Q4 | 0.42 |
| 2025 Q3 | 0.01 |
| 2025 Q2 | 0.08 |
| 2025 Q1 | 0.29 |
| 2024 Q4 | 0.12 |
| 2024 Q3 | 0.65 |
Last four quarters: NT$0.67
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.50 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 30,828 | 4.2% |
| 1,000–5,000 shares | 3,187 | 21.3% |
| 5,001–10,000 shares | 322 | 8.1% |
| 10,001–15,000 shares | 93 | 4.1% |
| 15,001–20,000 shares | 36 | 2.3% |
| 20,001–30,000 shares | 32 | 2.9% |
| 30,001–40,000 shares | 21 | 2.6% |
| 40,001–50,000 shares | 14 | 2.3% |
| 50,001–100,000 shares | 24 | 6.5% |
| 100,001–200,000 shares | 10 | 5.1% |
| 200,001–400,000 shares | 11 | 10.9% |
| 400,001–600,000 shares | 1 | 1.9% |
| 600,001–800,000 shares | 1 | 2.4% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 1 | 25.4% |
TDCC data for 2026-10-16: 1 holders own more than 1,000 lots (25.4% of shares), and 30,828 hold less than one lot (4.2%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 0 | 0 | 0 | 0 |
| 2026-10-15 | 10 | 0 | 0 | 10 |
| 2026-10-14 | -1 | 0 | 0 | -1 |
| 2026-10-13 | -1 | 0 | 0 | -1 |
| 2026-10-12 | 0 | 0 | 0 | 0 |
| 2026-10-08 | 1 | 0 | 0 | 1 |
| 2026-10-07 | 1 | 0 | 0 | 1 |
| 2026-10-06 | -3 | 0 | 0 | -3 |
| 2026-10-05 | -1 | 0 | 0 | -1 |
| 2026-10-02 | -1 | 0 | 0 | -1 |
| 2026-10-01 | -4 | 0 | 0 | -4 |
| 2026-09-30 | 14 | 0 | 0 | 14 |
| 2026-09-29 | 2 | 0 | 0 | 2 |
| 2026-09-24 | -1 | 0 | 0 | -1 |
| 2026-09-23 | 12 | 0 | 0 | 12 |
| 2026-09-22 | 1 | 0 | 0 | 1 |
| 2026-09-21 | -1 | 0 | 0 | -1 |
| 2026-09-18 | 0 | 0 | 0 | 0 |
| 2026-09-17 | 0 | 0 | 0 | 0 |
| 2026-09-16 | -1 | 0 | 0 | -1 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 27 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$38.00 (2026-10-19); 52-week range NT$37.55–58.70.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.